Abstract 1010: LIG1 deletion predicts chemotherapy resistance, chromosomal instability, and poor prognosis in triple negative breast cancer
Meenakshi Anurag(Baylor College of Medicine), Matthew J. Ellis(Guardant (United States)), Shankha Satpathy(Broad Institute), Anh Minh Tran Huynh(Baylor College of Medicine), George Miles(Baylor College of Medicine), Karsten Krug(Broad Institute), Kristen Otte, Viktoriya Korchina(Baylor College of Medicine), Steven A. Carr(Broad Institute), Michael T. Lewis(Baylor College of Medicine), Donna M. Muzny(Baylor College of Medicine), Lacey E. Dobrolecki(Baylor College of Medicine), Xuxu Gou(Baylor College of Medicine), HarshaVardhan Doddapaneni(Baylor College of Medicine), Bora Lim(Baylor College of Medicine), Jonathan T. Lei(Baylor College of Medicine), Kent C. Osborne(Baylor College of Medicine), Foluso O. Ademuyiwa(Washington University in St. Louis), Gloria V. Echeverria(Baylor College of Medicine), Yongchao Dou(Baylor College of Medicine), Michael A. Gillette(Broad Institute), Ana I. Robles(National Cancer Institute), Mothaffar F. Rimawi(Baylor College of Medicine), Henry Rodriguez(Cancer Clinic), Erik J. Bergstrom(Broad Institute), Tara Hiltke(National Cancer Institute), Tanmayi D. Vashist(Broad Institute), Bing Zhang(Baylor Genetics), Ian Hageman(Washington University in St. Louis), Beom‐Jun Kim(Ulsan College), Eric J. Jaehnig(Baylor College of Medicine)
Cited by 0
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
A global reference for human genetic variation
|Nature|2015|19.9k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
|New England Journal of Medicine|2013|2k